Skip to content
DataLookout
Start free
Menu

NCT07312526

Shanghai Clinical Cohort - Esophageal Cancer

StatusRecruiting
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 2116 to 3500 Show 4 more changesShow less
    • Eligibility criteria expanded, about 2 words
    • Sponsor refiled this as recruiting (was completed)
    • Study completion date: Mar 31, 2026 to Dec 31, 2026
    • Site details revised
  2. Trial completed
    • Primary and study completion pushed from Dec 31, 2025 to Mar 31, 2026
    • Site details revised
    v2
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Overal survival
Timeframe: From the date of enrollment until the date of death or loss of follow-up, assessed up to 10 years. Follow-up is scheduled every 3 months in the first 2 years. Every 6 months from the 2nd to the 5th year. Then once a year. Until death or loss of follow.

Arms and interventions

Procedures: esophagectomy

Sites

1 site in 1 country

  • Shanghai Chest HospitalShanghai, China